Related references
Note: Only part of the references are listed.Distinct lipid profile in haemolytic anaemia-related gallstones compared with the general gallstone
Ziqi Wan et al.
ANNALS OF MEDICINE (2023)
Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study
Helene T. Cronje et al.
BMC MEDICINE (2023)
Association between Gallstone Disease and Statin Use: A Nested Case-Control Study in Korea
Mi Jung Kwon et al.
PHARMACEUTICALS (2023)
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
J. Liu et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2023)
Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study
Lanlan Chen et al.
HEPATOLOGY (2022)
Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery
Sylke Haal et al.
OBESITY SURGERY (2022)
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
James Yarmolinsky et al.
PLOS MEDICINE (2022)
The evolution of mendelian randomization for investigating drug effects
Dipender Gill et al.
PLOS MEDICINE (2022)
Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis
Min Zhang et al.
LIPIDS IN HEALTH AND DISEASE (2022)
ukbpheno v1.0: An R package for phenotyping health-related outcomes in the UK Biobank
Ming Wai Yeung et al.
STAR PROTOCOLS (2022)
Polynomial Mendelian randomization reveals non-linear causal effects for obesity-related traits
Jonathan Sulc et al.
HUMAN GENETICS AND GENOMICS ADVANCES (2022)
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol
George N. Ioannou et al.
HEPATOLOGY COMMUNICATIONS (2022)
Multivariable Mendelian Randomization and Mediation
Eleanor Sanderson
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
Recent advances, novel targets and treatments for cholelithiasis; a narrative review
E. Swarne et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement
Veronika W. Skrivankova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
The power of genetic diversity in genome-wide association studies of lipids
Sarah E. Graham et al.
NATURE (2021)
Lipid Lowering and Alzheimer Disease Risk: A Mendelian Randomization Study
Dylan M. Williams et al.
ANNALS OF NEUROLOGY (2020)
Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses
Chris Wallace
PLOS GENETICS (2020)
Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics
Jean Morrison et al.
NATURE GENETICS (2020)
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Kausik K. Ray et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367
Luiz Sergio F. de Carvalho et al.
DIABETES CARE (2018)
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases (vol 50, 693, 2018)
Marie Verbanck et al.
NATURE GENETICS (2018)
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
Pim van der Harst et al.
CIRCULATION RESEARCH (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Interpreting findings from Mendelian randomization using the MR-Egger method (vol 32, pg 377, 2017)
Stephen Burgess et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities
Venexia M. Walker et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Mendelian Randomization
Connor A. Emdin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
Amand F. Schmidt et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Brian A. Ference et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gallstones
Frank Lammert et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease
Bo Kobbero Lauridsen et al.
EUROPEAN HEART JOURNAL (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Statin use and risk of gallstone disease: A meta-analysis
He-Ping Kan et al.
HEPATOLOGY RESEARCH (2015)
Instrumental Variable Analysis with a Nonlinear Exposure-Outcome Relationship
Stephen Burgess et al.
EPIDEMIOLOGY (2014)
Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice
Yan Xie et al.
JOURNAL OF LIPID RESEARCH (2014)
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
Claudia Giambartolomei et al.
PLOS GENETICS (2014)
Low-density lipoprotein cholesterol and risk of gallstone disease: A Mendelian randomization study and meta-analyses
Stefan Stender et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term Statin Use and the Risk of Gallstone Disease: A Population-based Case-Control Study
Rune Erichsen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
METAL: fast and efficient meta-analysis of genomewide association scans
Cristen J. Willer et al.
BIOINFORMATICS (2010)
Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms
Reecha Sofat et al.
CIRCULATION (2010)
Statin Use and the Risk of Cholecystectomy in Women
Chung-Jyi Tsai et al.
GASTROENTEROLOGY (2009)
Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy
Michael Bodmer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones
Helen H. Wang et al.
GASTROENTEROLOGY (2008)
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetirnibe
Ryan E. Temel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease
Juan Castro et al.
HEPATOLOGY (2007)
Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones
Ludwig Amigo et al.
GASTROENTEROLOGY (2006)
Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil
IJAM Jonkers et al.
GUT (2003)